Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 68 citing articles:

Hypoxia and brain aging: Neurodegeneration or neuroprotection?
Johannes Burtscher, Robert T. Mallet, Martin Burtscher, et al.
Ageing Research Reviews (2021) Vol. 68, pp. 101343-101343
Open Access | Times Cited: 206
Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons
Goutham K. Ganjam, Kathrin Bolte, Lina A. Matschke, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 11
Open Access | Times Cited: 135
Leigh Syndrome Mouse Model Can Be Rescued by Interventions that Normalize Brain Hyperoxia, but Not HIF Activation
Isha H. Jain, L. Zazzeron, Olga Goldberger, et al.
Cell Metabolism (2019) Vol. 30, Iss. 4, pp. 824-832.e3
Open Access | Times Cited: 107
Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease
Еlena V. Mitroshina, Maria O. Savyuk, Evgeni Ponimaskin, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 81
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
Yumin Wang, Luyan Gao, Jichao Chen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 75
Mitochondria bridge HIF signaling and ferroptosis blockage in acute kidney injury
Wenju Li, Zhidan Xiang, Yuexian Xing, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 47
The Role of Oxygen Homeostasis and the HIF-1 Factor in the Development of Neurodegeneration
Еlena V. Mitroshina, Maria V. Vedunova
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4581-4581
Open Access | Times Cited: 10
Yeast β-D-glucan exerts antitumour activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis
Ningning Wang, Hongzhi Liu, Guijun Liu, et al.
Redox Biology (2020) Vol. 32, pp. 101495-101495
Open Access | Times Cited: 60
Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications
Zhihong Li, Qidong You, Xiaojin Zhang
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 12, pp. 5725-5749
Closed Access | Times Cited: 55
Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model
Ayesha Singh, James W. Wilson, Christopher J. Schofield, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 52
Roxadustat: Not just for anemia
Xiaoyu Zhu, Lili Jiang, Xuejiao Wei, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases
Mengqiu Miao, Mengqiu Wu, Yuting Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 28
Acute Methylmercury Exposure and the Hypoxia-Inducible Factor-1α Signaling Pathway under Normoxic Conditions in the Rat Brain and Astrocytes in Vitro
Jie Chang, Bobo Yang, Yun Zhou, et al.
Environmental Health Perspectives (2019) Vol. 127, Iss. 12
Open Access | Times Cited: 47
Hypoxia Conditioning as a Promising Therapeutic Target in Parkinson's Disease?
Johannes Burtscher, Muhammed Muazzam Kamil Syed, Hilal A. Lashuel, et al.
Movement Disorders (2021) Vol. 36, Iss. 4, pp. 857-861
Closed Access | Times Cited: 36
Hypoxia Signaling in Parkinson’s Disease: There Is Use in Asking “What HIF?”
Laura Lestón Pinilla, Aslihan Ugun‐Klusek, Sergio Rutella, et al.
Biology (2021) Vol. 10, Iss. 8, pp. 723-723
Open Access | Times Cited: 36
Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability
Mengqiu Wu, Wei‐Yi Chen, Mengqiu Miao, et al.
Clinical Science (2021) Vol. 135, Iss. 14, pp. 1707-1726
Open Access | Times Cited: 33
Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease
Mengyuan Guo, Xunming Ji, Jia Liu
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 23
Roxadustat: do we know all the answers?
Qiuyu Li, Qian-Wen Xiong, Xuefeng Yao, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 14
Parkinson’s Disease and MicroRNAs: A Duel Between Inhibition and Stimulation of Apoptosis in Neuronal Cells
Mohamed J. Saadh, Ahmed Faisal, Mohaned Adil, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 8552-8574
Closed Access | Times Cited: 5
Roxadustat improves diabetic myocardial injury by upregulating HIF-1α/UCP2 against oxidative stress
Tingting Fang, Congcong Ma, Bing Yang, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, FG4592, Induces Endogenous Metallothionein3 Expression in Human Neuronal Cell Line, ReNcell CX Cells
Mizuki Tsuru, Taisei Ito, Kiyonobu Komai, et al.
Biological and Pharmaceutical Bulletin (2025) Vol. 48, Iss. 2, pp. 137-143
Open Access
Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease
Lisa Uchida, Tetsuhiro Tanaka, Hisako Saito, et al.
AJP Renal Physiology (2019) Vol. 318, Iss. 2, pp. F388-F401
Open Access | Times Cited: 40
HIF-1α/microRNA-128-3p axis protects hippocampal neurons from apoptosis via the Axin1-mediated Wnt/β-catenin signaling pathway in Parkinson’s disease models
Guangping Zhang, Luzhu Chen, Jing Liu, et al.
Aging (2020) Vol. 12, Iss. 5, pp. 4067-4081
Open Access | Times Cited: 36
Hypoxia in Alzheimer's disease: effects of hypoxia inducible factors
Ruoli Chen, H.T. Hassan
Neural Regeneration Research (2020) Vol. 16, Iss. 2, pp. 310-310
Open Access | Times Cited: 32
A Rationale for Hypoxic and Chemical Conditioning in Huntington’s Disease
Johannes Burtscher, Vittorio Maglione, Alba Di Pardo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 582-582
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top